Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002029757 | SCV002108134 | likely benign | Hereditary spastic paraplegia 11 | 2024-02-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002545298 | SCV003634385 | uncertain significance | Inborn genetic diseases | 2022-06-17 | criteria provided, single submitter | clinical testing | The c.6447C>A (p.H2149Q) alteration is located in exon 34 (coding exon 34) of the SPG11 gene. This alteration results from a C to A substitution at nucleotide position 6447, causing the histidine (H) at amino acid position 2149 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |